Evidence map›Paper›PMID 36363970›Full record

ArticleMolecules (Basel, Switzerland)2022

Synthesis and Biological Evaluation of PEGylated MWO

Junna Jiao, Zhuang Qian, Yurong Wang, Mei Liu, Liye Fan, Mengqing Liu, Zichen Hao, Junrong Jiao, Zhuangwei Lv

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Junna JiaoDepartment of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang 453003, China.
Zhuang QianInstitutes of Health Central Plains, Xinxiang Medical University, Xinxiang 453003, China.
Yurong WangDepartment of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang 453003, China.
Mei LiuDepartment of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang 453003, China.
Liye FanDepartment of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang 453003, China.
Mengqing LiuDepartment of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang 453003, China.
Zichen HaoDepartment of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang 453003, China.
Junrong JiaoKey Lab for Special Functional Materials of Ministry of Education, National & Local Joint Engineering Research Center for High-Efficiency Display and Lighting Technology, School of Materials Science and Engineering, Collaborative Innovation Center of Nano Functional Materials and Applications, Henan University, Kaifeng 475004, China.ORCID 0000-0002-9252-2409
Zhuangwei LvXinxiang Key Laboratory of Tumor Vaccine and Immunotherapy, Xinxiang Medical University, Xinxiang 453003, China.
Xinxiang Medical University · CNHenan University · CN

Funding

Key Scientific and Technological Project of Henan Province 212102310748Key Scientific Research Foundation of the Higher Education Institutions of Henan Province 22A320044 and 22A320041National Natural Science Foundation of China 22102049
6 · The paper itself

Abstract

Sonodynamic therapy (SDT) triggered by ultrasound (US) has attracted increasing attention owing to its ability to overcome critical limitations, including low tissue-penetration depth and phototoxicity in photodynamic therapy (PDT). Biogenic metal oxide nanoparticles (NPs) have been used as anti-cancer drugs due to their biocompatibility properties with most biological systems. Here, sonosensitizer MWO

Indexed as

Lymphoma, Large B-Cell, DiffuseMetal NanoparticlesNanoparticlesUltrasonic TherapyCell Line, TumorHumansMolecular Docking SimulationOxidesPolyethylene GlycolsReactive Oxygen SpeciesOxidesPolyethylene GlycolsReactive Oxygen Speciesactivation-induced cytidine deaminaseDLBCL treatmentinhibitorsPEGylated MWO4 nanoparticles

Identifiers

PMID36363970
PMCPMC9654119
OpenAlexW4307269143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.